Search information pages
2. Why submit to BMC Hematology?
Submit your research to BMC Hematology to take advantage of:
Rapid peer review
Our insistence on fast and thorough peer review enables us to process manuscripts quickly; we aim to reach initial decisions within six weeks.
All articles published in BMC Hematology are open access (freely available on the journal website, with the copyright retained by the author). Research articles are deposited in at least one widely and internationally-recognized open access repository such as PubMed Central, complying with the NIH Public Access Policy and the Wellcome Trust Open Access Policy. To cover the cost of open access publishing we levy an article-processing charge.
High visibility within the field
Your work is freely accessible to a global audience. In addition, articles are available through PubMed Central, and are listed/indexed by PubMed the US National Library of Medicine's full-text repository of life science literature, at INIST in France and in e-Depot, the National Library of the Netherlands' digital archive of all electronic publications. We are also in discussion with other permanent digital archives including the British Library.
- What is BMC Hematology?
- Why submit to BMC Hematology?
- What is Open Access?
- If my article is published, how will it be cited?
- If my article is published, which bibliographic databases will it be indexed in?
- How can I order reprints?
- What is the copyright policy of BMC Hematology?
- Do I need permission to reproduce materials published in BMC Hematology?
- What are the benefits of registering on the journal website?
- Is there a printed version of the journal?
- How can I ensure that I receive BMC Hematology's emails?
- What is BioMed Central?